Skip to main content
. 2008 May 12;105(20):7171–7176. doi: 10.1073/pnas.0710802105

Table 1.

Activity of ER ligands

Compound Receptor affinity
ER-dependent cell assays
Ki α, nM MCF-7 (IC50), nM Ishikawa (IC50), nM Inhibition, % Relative (EC50), nM Stimulation, %
4-hydroxytamoxifen 0.20 (0.17, n = 4) 0.63 (0.06, n = 2) 340.95 (706, n = 295) 55.8 (20.8, n = 417) 2.45 (6.6, n = 404) 131.3 (33.3, n = 407)
Lasofoxifene 0.34 (0.18, n = 5) 0.68 (0.01, n = 2) 6.97 (1.9, n = 6) 87.5 (8.5, n = 6) 0.22 (0.08, n = 6) 65.96 (17.5, n = 6)
LY165176 0.21 (0.08, n = 6) 6.1 (n = 1) 233.6 (123.5, n = 2) 61.5 (6.3, n = 2) 0.28 (0.25, n = 2) 128.7 (48.6, n = 2)
LY156681 0.44 (0.05, n = 3) 2.89 (1.7, n = 3) NA 33.85 (3.5, n = 4) 4.67 (0.89, n = 4) 164.4 (30, n = 4)
Raloxifene (38) 0.37 (0.09, n = 3) 0.37 (0.03, n = 2) 4.32 (1.69, n = 8) 96.8 (7.0, n = 8) NA 28.6 (8.5, n = 8)
Bazedoxifene 0.65 (0.17, n = 3) 0.47 (n = 1) 3.6 (1.8, n = 274) 99.1 (8.7, n = 276) NA 7.6 (8.8, n = 267)
LY117018 0.32 (0.07, n = 3) 1.05 (0.55, n = 34) 3.42 (0.25, n = 2) 83.3 (2.1, n = 2) 0.39 (0.19, n = 2) 37.2 (17.6, n = 2)
Estradiol 0.16 (0.07, n = 380) NA NA NA 0.81 (1.13, n = 383) 581.2 (273, n = 383)
DES 0.09 (0.05, n = 3) NA NA NA 0.11 (0.01, n = 2) 410.7 (136.4, n = 2)
LY88074 0.67 (0.25, n = 3) NA NA 20.1 (7.4, n = 2) 105.7 (40.2, n = 2) 179.8 (34.5, n = 2)
ICI182780 3.0 (0.23, n = 4) 0.29 (0.20, n = 3) 0.58 (0.5, n = 383) 101.18 (7.06, n = 386) NA 7.8 (10.8, n = 375)

MCF-7 values are half-maximal inhibition concentrations (nM) that block stimulation by 10 pM estradiol. Ishikawa agonism is the percentage increase in alkaline phosphatase compared with tamoxifen, whereas Ishikawa antagonism is the efficacy (%) of blocking 2 nM estradiol response, and the IC50 values are the compound concentration needed to block 50% of this estradiol stimulation. The numbers in parentheses are the SDs. Values without SD were run once.